- Home
- BCML vs CMPX Comparison
BCML vs CMPX Comparison
Compare BCML & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- CMPX
- Stock Information
- Founded
- BCML 2004
- CMPX 2014
- Country
- BCML United States
- CMPX United States
- Employees
- BCML N/A
- CMPX N/A
- Industry
- BCML Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- CMPX Health Care
- Exchange
- BCML Nasdaq
- CMPX Nasdaq
- Market Cap
- BCML 294.2M
- CMPX 291.8M
- IPO Year
- BCML N/A
- CMPX N/A
- Fundamental
- Price
- BCML $27.65
- CMPX $2.97
- Analyst Decision
- BCML
- CMPX Strong Buy
- Analyst Count
- BCML 0
- CMPX 9
- Target Price
- BCML N/A
- CMPX $12.67
- AVG Volume (30 Days)
- BCML 30.2K
- CMPX 839.1K
- Earning Date
- BCML 07-21-2025
- CMPX 08-11-2025
- Dividend Yield
- BCML 2.87%
- CMPX N/A
- EPS Growth
- BCML N/A
- CMPX N/A
- EPS
- BCML 2.10
- CMPX N/A
- Revenue
- BCML $95,714,000.00
- CMPX $850,000.00
- Revenue This Year
- BCML $1.24
- CMPX N/A
- Revenue Next Year
- BCML $6.52
- CMPX N/A
- P/E Ratio
- BCML $13.29
- CMPX N/A
- Revenue Growth
- BCML N/A
- CMPX N/A
- 52 Week Low
- BCML $20.25
- CMPX $0.87
- 52 Week High
- BCML $30.13
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- BCML 48.77
- CMPX 66.60
- Support Level
- BCML $27.40
- CMPX $2.64
- Resistance Level
- BCML $29.46
- CMPX $3.00
- Average True Range (ATR)
- BCML 0.79
- CMPX 0.18
- MACD
- BCML -0.06
- CMPX 0.02
- Stochastic Oscillator
- BCML 27.02
- CMPX 90.00
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.